Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioHorizons' products—including dental implants, biologics for hard and soft tissue regeneration, prosthetics, and digital dentistry solutions—are commercially available worldwide. Their dental implants have demonstrated a high average success rate (~99%) in clinical use. The company’s proprietary Laser-Lok surface technology has been shown to promote connective tissue attachment and inhibit epithelial downgrowth around the implant site. AlloDerm SELECT RTM supports rapid revascularization and cell repopulation for strong repair in soft-tissue applications. TeethXpress enables immediate load protocols for full or partial edentulism with biomechanical stability.[1][2][3][6][8]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioHorizons.